Regulus Therapeutics (RGLS) Short Interest Ratio & Short Volume → How Biden has already won 2024 (From Porter & Company) (Ad) Free RGLS Stock Alerts $2.04 +0.02 (+0.99%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Regulus Therapeutics Short Interest DataCurrent Short Interest2,880,000 sharesPrevious Short Interest4,210,000 sharesChange Vs. Previous Month-31.59%Dollar Volume Sold Short$5.82 millionShort Interest Ratio0.9 Days to CoverLast Record DateMay 15, 2024Outstanding Shares65,470,000 sharesFloat Size52,900,000 sharesShort Percent of Float5.44%Today's Trading Volume525,278 sharesAverage Trading Volume2,002,724 sharesToday's Volume Vs. Average26% Short Selling Regulus Therapeutics ? Sign up to receive the latest short interest report for Regulus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRGLS Short Interest Over TimeRGLS Days to Cover Over TimeRGLS Percentage of Float Shorted Over Time Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade Regulus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20242,880,000 shares $5.82 million -31.6%5.4%0.9 $2.02 4/30/20244,210,000 shares $9.68 million -32.9%7.3%1.4 $2.30 4/15/20246,270,000 shares $17.43 million +15.7%10.9%2.1 $2.78 3/31/20245,420,000 shares $15.61 million +5.7%9.4%1.8 $2.88 3/15/20245,130,000 shares $10.82 million +9,244.3%13.0%1.8 $2.11 2/29/202454,900 shares $80,703.00 -43.4%0.3%1.4 $1.47 Get the Latest News and Ratings for RGLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202497,000 shares $143,560.00 -16.6%0.6%2.6 $1.48 1/31/2024116,300 shares $147,701.00 -7.3%0.7%4.4 $1.27 1/15/2024125,500 shares $163,150.00 -9.3%0.7%5.1 $1.30 12/31/2023138,400 shares $177,152.00 -6.6%0.8%6.9 $1.28 12/15/2023148,100 shares $202,897.00 -0.1%0.9%7.6 $1.37 11/30/2023148,200 shares $194,142.00 -18.3%0.9%4.4 $1.31 11/15/2023181,300 shares $252,007.00 -5.2%1.0%4.9 $1.39 10/31/2023191,200 shares $231,352.00 -0.7%1.1%5.4 $1.21 10/15/2023192,600 shares $242,676.00 -1.0%1.2%5.5 $1.26 9/30/2023194,500 shares $266,465.00 -0.2%1.2%5.6 $1.37 9/15/2023194,800 shares $331,160.00 +4.2%1.2%5.6 $1.70 8/31/2023187,000 shares $291,720.00 -10.2%1.1%5.7 $1.56 8/15/2023208,300 shares $281,205.00 -3.7%1.3%9.6 $1.35 7/31/2023216,300 shares $302,820.00 -3.9%1.3%7.8 $1.40 7/15/2023225,000 shares $328,500.00 -2.5%1.4%7.7 $1.46 6/30/2023230,700 shares $339,129.00 +6.5%1.4%4.1 $1.47 6/15/2023216,700 shares $312,048.00 +3.0%1.3%3.4 $1.44 5/31/2023210,300 shares $273,390.00 -17.1%1.3%3.1 $1.30 5/15/2023253,700 shares $393,235.00 +26.0%1.6%3.8 $1.55 4/30/2023201,300 shares $268,735.50 +18.1%1.4%3.4 $1.34 4/15/2023170,500 shares $202,895.00 -13.9%1.2%2.6 $1.19 3/31/2023198,000 shares $167,805.00 +11.1%1.3%4.8 $0.85 3/15/2023178,200 shares $215,622.00 -3.7%1.2%4 $1.21 2/28/2023185,100 shares $248,034.00 -1.9%1.3%4.1 $1.34 2/15/2023188,600 shares $262,154.00 -6.8%1.3%4.2 $1.39 1/31/2023202,400 shares $291,456.00 -3.2%1.4%4.3 $1.44 1/15/2023209,000 shares $311,410.00 +0.8%1.4%4.7 $1.49 12/30/2022207,400 shares $284,138.00 -10.8%1.4%4.7 $1.37 12/15/2022232,600 shares $327,966.00 -16.2%1.6%5.4 $1.41 11/30/2022277,500 shares $474,525.00 -2.6%1.9%0.3 $1.71 11/15/2022284,900 shares $490,028.00 +5.1%2.0%0.3 $1.72 10/31/2022271,100 shares $420,205.00 -1.7%N/A0.3 $1.55 10/15/2022275,900 shares $449,717.00 -7.4%N/A0.3 $1.63 9/30/2022297,900 shares $506,430.00 -49.9%N/A0.3 $1.70Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. 9/15/2022594,600 shares $1.24 million +98.7%N/A0.7 $2.09 8/31/2022299,300 shares $425,006.00 -15.2%N/A0.4 $1.42 8/15/2022353,000 shares $638,930.00 +56.1%N/A3 $1.81 7/31/2022226,200 shares $364,182.00 -7.1%N/A1 $1.61 7/15/2022243,500 shares $560,050.00 +1.4%N/A1.2 $2.30 6/30/2022240,100 shares $497,007.00 -91.3%N/A1.2 $2.07 6/15/20222,770,000 shares $678,927.00 -9.2%N/A1.4 $0.25 5/31/20223,050,000 shares $873,825.00 -30.8%N/A1.5 $0.29 5/15/20224,410,000 shares $948,150.00 +53.1%N/A2 $0.22 4/30/20222,880,000 shares $581,760.00 -10.8%N/A2.7 $0.20 4/15/20223,230,000 shares $823,650.00 -2.4%N/A2.8 $0.26 3/31/20223,310,000 shares $986,380.00 +1.5%N/A2.3 $0.30 3/15/20223,260,000 shares $867,160.00 +21.2%N/A2.3 $0.27 2/28/20222,690,000 shares $605,250.00 -17.5%N/A1.9 $0.23 2/15/20223,260,000 shares $815,326.00 +4.5%N/A2.5 $0.25 1/31/20223,120,000 shares $769,704.00 +24.8%4.2%2.2 $0.25 1/15/20222,500,000 shares $617,500.00 -8.8%3.3%1.5 $0.25 12/31/20212,740,000 shares $863,100.00 -18.7%4.1%1.3 $0.32 12/15/20213,370,000 shares $1.18 million -0.6%5.1%1.6 $0.35 11/30/20213,390,000 shares $1.31 million -19.7%4.5%1.7 $0.39 11/15/20214,220,000 shares $1.76 million -4.5%N/A2.1 $0.42 10/29/20214,420,000 shares $2.04 million -8.3%N/A2.3 $0.46 10/15/20214,820,000 shares $2.34 million -8.5%N/A2.9 $0.49 9/30/20215,270,000 shares $3.64 million +6.0%N/A6.5 $0.69 9/15/20214,970,000 shares $3.48 million +0.4%N/A4 $0.70 8/31/20214,950,000 shares $3.84 million -5.9%N/A1.7 $0.78 8/13/20215,260,000 shares $3.53 million -0.8%N/A1.7 $0.67 7/30/20215,300,000 shares $3.71 million -12.3%8.2%1.7 $0.70 7/15/20216,040,000 shares $4.35 million -2.6%9.3%1.9 $0.72 6/30/20216,200,000 shares $5.04 million +4.7%9.6%1.9 $0.81 6/15/20215,920,000 shares $5.52 million +0.2%9.1%2 $0.93 5/28/20215,910,000 shares $5.83 million No Change9.1%1.6 $0.99 5/14/20215,910,000 shares $4.85 million -5.4%N/A2.1 $0.82 4/30/20216,250,000 shares $9.19 million -3.0%N/A2.1 $1.47 4/15/20216,440,000 shares $8.76 million -3.5%N/A2 $1.36 3/31/20216,670,000 shares $10.41 million +31.3%N/A2.1 $1.56 3/15/20215,080,000 shares $9.96 million +61.8%N/A1.5 $1.96 2/26/20213,140,000 shares $4.11 million +13.8%N/A1.2 $1.31 2/12/20212,760,000 shares $4.50 million +16.0%N/A1.1 $1.63 1/29/20212,380,000 shares $3.33 million +31.5%N/A1.1 $1.40 1/15/20211,810,000 shares $2.15 million +24.0%N/A0.9 $1.19 12/31/20201,460,000 shares $1.88 million +35.2%N/A0.9 $1.29 12/15/20201,080,000 shares $1.24 million +54.8%N/A0.7 $1.15 11/30/2020697,800 shares $444,289.26 -30.0%N/A0.9 $0.64 11/15/2020997,100 shares $518,492.00 +7.0%N/A2.1 $0.52 10/30/2020932,300 shares $444,520.64 +12.9%N/A1.8 $0.48 10/15/2020826,100 shares $450,637.55 -6.8%N/A0.6 $0.55 9/30/2020885,900 shares $455,352.60 -19.5%N/A0.5 $0.51 9/15/20201,100,000 shares $611,600.00 -4.4%N/A0.5 $0.56 8/31/20201,150,000 shares $609,500.00 -27.7%N/A0.4 $0.53Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. 8/14/20201,590,000 shares $969,900.00 -3.6%N/A0.6 $0.61 7/31/20201,650,000 shares $1.16 million +131.2%N/A0.6 $0.70 7/15/2020713,800 shares $548,269.78 +189.8%N/A0.4 $0.77 6/30/2020246,300 shares $176,104.50 -65.8%N/A0.2 $0.72 6/15/2020720,200 shares $677,060.02 +25.6%N/A0.6 $0.94 5/29/2020573,600 shares $430,200.00 -15.9%N/A1 $0.75 5/15/2020681,900 shares $408,458.10 +17.9%N/A2.1 $0.60 4/30/2020578,500 shares $296,770.50 +3.9%N/A2.1 $0.51 4/15/2020556,600 shares $263,438.78 +2.8%3.5%2.7 $0.47 3/31/2020541,500 shares $254,505.00 -2.7%3.4%3 $0.47 3/13/2020556,700 shares $250,515.00 -0.3%3.5%4.7 $0.45 2/28/2020558,200 shares $245,608.00 -1.1%3.5%1.9 $0.44 2/14/2020564,100 shares $383,588.00 -16.5%3.5%1.9 $0.68 1/31/2020675,300 shares $492,969.00 +3.1%4.2%2.4 $0.73 1/15/2020654,800 shares $628,608.00 +35.8%3.8%2.4 $0.96 12/31/2019482,200 shares $564,174.00 +59.1%2.8%1.9 $1.17 8/15/2019647,300 shares $375,434.00 +50.4%11.0%3.2 $0.58 RGLS Short Interest - Frequently Asked Questions What is Regulus Therapeutics' current short interest? Short interest is the volume of Regulus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 2,880,000 shares of RGLS short. 5.44% of Regulus Therapeutics' shares are currently sold short. Learn More on Regulus Therapeutics' current short interest. What is a good short interest ratio for Regulus Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RGLS shares currently have a short interest ratio of 1.0. Learn More on Regulus Therapeutics's short interest ratio. What is a good short interest percentage for Regulus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.44% of Regulus Therapeutics' floating shares are currently sold short. Is Regulus Therapeutics' short interest increasing or decreasing? Regulus Therapeutics saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 2,880,000 shares, a decrease of 31.6% from the previous total of 4,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Regulus Therapeutics' float size? Regulus Therapeutics currently has issued a total of 65,470,000 shares. Some of Regulus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Regulus Therapeutics currently has a public float of 52,900,000 shares. How does Regulus Therapeutics' short interest compare to its competitors? 5.44% of Regulus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Regulus Therapeutics: Rigel Pharmaceuticals, Inc. (3.22%), Alimera Sciences, Inc. (0.20%), Fortress Biotech, Inc. (11.49%), Emergent BioSolutions Inc. (11.97%), XOMA Co. (2.09%), Vanda Pharmaceuticals Inc. (5.08%), Verastem, Inc. (3.94%), Lexicon Pharmaceuticals, Inc. (9.45%), Cartesian Therapeutics, Inc. (13.69%), Karyopharm Therapeutics Inc. (14.92%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Regulus Therapeutics stock? Short selling RGLS is an investing strategy that aims to generate trading profit from Regulus Therapeutics as its price is falling. RGLS shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Regulus Therapeutics? A short squeeze for Regulus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RGLS, which in turn drives the price of the stock up even further. How often is Regulus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RGLS, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Rigel Pharmaceuticals Short Interest Alimera Sciences Short Interest Fortress Biotech Short Interest Emergent BioSolutions Short Interest XOMA Short Interest Vanda Pharmaceuticals Short Interest Verastem Short Interest Lexicon Pharmaceuticals Short Interest Cartesian Therapeutics Short Interest Karyopharm Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RGLS) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon’s New Device is About to Shock the WorldInvestorPlaceHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regulus Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.